Definitive Contract HHSN261201100113C
Award Date 9/30/11
Potential Completion Date 10/31/14
Potential Value $1.5M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Buffalo, NY 14203, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- <p>This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Buffalo Biolabs, LLC, a small business. The contract, awarded on September 20, 2012, is for "OTHER FUNCTIONS R & D - MEDICAL BIOMEDICAL (BASIC RESEARCH)" and has a ceiling value of $200,000.00. The contract type is Definitive Contract with a Firm Fixed Price pricing type. The period of performance ends on August 5, 2013. This contract award is set aside for total small business.</p>
- This is a federal contract award from the Department of Health and Human Services (HHS) to Buffalo Biolabs, LLC, a small business located in Buffalo, NY. The contract is for a Small Business Innovation Research (SBIR) Program Phase I research project in the biomedical field, with a total contract value of $148,725.00 and a completion date of March 31, 2010. The contract is a Firm Fixed Price Definitive Contract, which indicates the scope of work and deliverables were pre-determined. As a SBIR...
- <p>This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Buffalo Biolabs, LLC, a small business located in Buffalo, New York. The contract is for basic physical sciences research with a firm fixed price of $149,987 and a period of performance ending on March 31, 2010. The contract was awarded on September 30, 2009 and has a total small business set-aside designation.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...
- <p>This is a $299,999.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Innogenomics Technologies, L.L.C., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development in the area of biomedical (basic research). It was awarded on September 22, 2015 with a final completion date of March 21, 2017. The contract has a total small business set-aside designation.</p>
- This is a $2,250,351.00 Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a civilian agency, to Provid Pharmaceuticals Inc., a for-profit small business organization. The contract is for the MEDICINAL CHEMISTRY LEAD OPTIMIZATION, (PHASE II) SBIR TOPIC 198 research project under the Small Business Innovation Research (SBIR) program. The contract was awarded on August 31, 2005 and has an ultimate completion date of May 31, 2008. This contract is set aside for small...
- <p>This is a $1,496,276.00 Cost Plus Fixed Fee contract awarded by the National Cancer Institute (NCI), a civilian agency, to Cellerant Therapeutics, Inc. The contract is for the SBIR (Small Business Innovation Research) Phase II development of novel therapeutic agents that target cancer stem cells, under Topic 326. The contract has a total small business set-aside designation and was awarded on September 19, 2016 with an ultimate completion date of April 16, 2018.</p>
- <p>This is a $150,000 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Bioptix Diagnostics, Inc., a for-profit manufacturer. The contract is for Phase I of a Small Business Innovation Research (SBIR) project under Topic 281. The contract has a completion date of June 29, 2011. As an SBIR award, this contract was set aside for small businesses.</p>
- <p>This is a cost-plus-fixed-fee SBIR Phase II contract awarded by the National Cancer Institute (NCI), a civilian agency, to LP Therapeutics, Inc. for the development of novel therapeutic agents targeting cancer stem cells. The contract has a total ceiling value of $1,489,000.12 and a period of performance ending on March 18, 2019. The contract was set aside for small businesses. No information is provided about major subcontractors.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a...